- Nobel Prize winner to address gathering at GYYS 2019
- Merck wins Life Science Industry Award
- Immunocore names David Berman as Head of R&D
- ZhongAn, Grab unite to create digital Insurance biz in SE Asia
- Seres Therapeutics announces CEO transition
- Exelixis announces USFDA approval of CABOMETYX
- Patient Specific 3D Printed implant set to market globally
- Roche launches uPath enterprise software for digital pathology
- Innovent announces dosing of patient in a Ph1 clinical trial of Anti-CD47 MAb
- Lianluo Smart announces availability of sleep diagnostic offering in more than forty hospitals
- InVivo Therapeutics appoints Richard Christopher as CFO
- PharmaCyte Biotech announces encapsulation of live cells for clinical trials in pancreatic cancer
- Walgreens, Microsoft to transform health care delivery
- Ironwood Pharma announces Linzess approval in China
-
World | 02 January 2019 | News
AI predicts cancer patients’ symptoms
Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is ...Read more
Japan | 02 January 2019 | News
Researchers discover laminin which can convert stem cells into retinal-like cells
Researchers from Osaka University in Japan have discovered a way to convert human pluripotent stem cells into ...Read more
-
China | 16 January 2019 | News
Ironwood Pharma announces Linzess approval in China
Ironwood Pharmaceuticals, Inc., a US based commercial biotechnology company, has announced that the National M...Read more
-
World | 16 January 2019 | News
InVivo Therapeutics appoints Richard Christopher as CFO
InVivo Therapeutics Holdings Corp, a research and clinical-stage biomaterials and biotechnology company with a...Read more
-
World | 16 January 2019 | News
Patient Specific 3D Printed implant set to market globally
Additive Orthopaedics, LLC., the leader in 3D printed orthopaedic foot and ankle devices, announces that is ha...Read more
-
World | 03 January 2019 | News
USFDA approves Portola Pharmaceuticals’ Andexxa®
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Compan...Read more
Health 4.0 boosts Asia MedTech, Bio-pharma in 2019
Asia is a region of stark contrasts, with approximately 4.5 billion people – some 60 per cent of the world’s population – living in countries with a rich diversity of economic, political, and demographic constituents. In the coming year Asia will become a major hub for MedTech and Bio-Pharma activities for both local as well multinational companies.
Biotech companies in the region are also actively partnering with leading global biopharmaceutical companies on both the R&D and commercial fronts. Asset-level partnership remains very active during 2019. According to McKinsey Asia has the potential to leapfrog in the digital-health segment. Asia has an opportunity to take the lead in developing big data/advanced analytics solutions and technology platforms, with the potential to contribute to the global healthcare ecosystem.
